学术探索
学术期刊
新闻热点
数据分析
智能评审

DRUG PHARMACOKINETICS IN THE OBESE

被引：45
作者：
CHEYMOL, G
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1988年 / 2卷 / 03期
关键词：
D O I：
10.1111/j.1472-8206.1988.tb00635.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：239 / 256
页数：18
相关论文
共 42 条
[1]   IBUPROFEN DISPOSITION IN OBESE INDIVIDUALS [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
ARTHRITIS AND RHEUMATISM, 1985, 28 (10) :1117-1121
[2]   THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
DIVOLL, M ;
SMITH, RB ;
SHADER, RI .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :177-183
[3]   DRUG DISPOSITION IN OBESE HUMANS - AN UPDATE [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
CLINICAL PHARMACOKINETICS, 1986, 11 (03) :199-213
[4]   PROLONGATION OF DRUG HALF-LIFE DUE TO OBESITY - STUDIES OF DESMETHYLDIAZEPAM (CLORAZEPATE) [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
DIVOLL, M ;
SHADER, RI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) :942-944
[5]   CAFFEINE DISPOSITION IN OBESITY [J].
ABERNETHY, DR ;
TODD, EL ;
SCHWARTZ, JB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (01) :61-66
[6]  
ABERNETHY DR, 1984, CLIN PHARMACOL THER, V35, P225
[7]  
ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[8]   LIDOCAINE DISPOSITION IN OBESITY [J].
ABERNETHY, DR ;
GREENBLATT, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) :1183-1186
[9]  
ABERNETHY DR, 1985, FED PROC, V44, P1128
[10]   DIGOXIN DISPOSITION IN OBESITY - CLINICAL PHARMACOKINETIC INVESTIGATION [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
SMITH, TW .
AMERICAN HEART JOURNAL, 1981, 102 (04) :740-744
12345